Join Gamida Cell for a virtual fireside chat with thought leader Gary Schiller, MD, FACP, Professor of Medicine and Director of the Hematological Malignancy/Stem Cell Transplant Program at the David Geffen School of Medicine at UCLA, who will discuss his experience working with patients in need of allogeneic stem cell transplant.

Dr. Schiller will also discuss the patient journey from diagnosis to transplant, the decision-making process for donor source selection, and his experience with Omisirge^® (omidubicel-onlv), an FDA-approved nicotinamide modified allogeneic hematopoietic progenitor cell therapy.

A live question and answer session will follow the fireside chat.

Visit Omisirge.com to learn more and see Full Prescribing Information, including Boxed Warning here.